SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Three Dyne Therapeutics insiders sold a combined $5.02M in shares over…

Dyne Therapeutics, Inc. · CLUSTER filed Jun 30, 2026 at 19:05 ET

At the news

NEUTRALIMPACT 5/10

CLUSTER filed Jun 30, 2026 at 19:05 ET

Three Dyne Therapeutics insiders sold a combined $5.02M in shares over a 6-day window, led by Director Rhodes ($4.9M). CFO Lucera sold a small amount ($48K). The sales follow a recent $50M borrowing under an expanded $400M Hercules debt facility (8-K on 6/17). Total selling represents ~0.14% of market cap, a modest amount that is not alarming given the pre-revenue biotech context.

  • Insider cluster: 3 insiders sold 5 trades totaling $5.02M from June 23-29.
  • Director Jason Rhodes sold $5.0M (bulk of sales); CFO Erick Lucera sold $48K.
  • Sales follow June 17 debt facility expansion ($50M draw, $400M total capacity).
  • Total sales represent ~0.14% of DYN's $3.5B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access